{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T22:16:35Z","timestamp":1767910595301,"version":"3.49.0"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2002,7,1]],"date-time":"2002-07-01T00:00:00Z","timestamp":1025481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2002,7,1]],"date-time":"2002-07-01T00:00:00Z","timestamp":1025481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2002,7]]},"DOI":"10.1023\/a:1020001912248","type":"journal-article","created":{"date-parts":[[2003,3,15]],"date-time":"2003-03-15T13:24:27Z","timestamp":1047734667000},"page":"285-300","source":"Crossref","is-referenced-by-count":19,"title":["Significance and Control of Cardiac Arrhythmias in Patients with Congestive Cardiac Failure"],"prefix":"10.1007","volume":"7","author":[{"given":"Bramah N.","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"5094287_CR1","doi-asserted-by":"crossref","first-page":"3B","DOI":"10.1016\/0002-9149(86)90991-4","volume":"87","author":"GS Francis","year":"1986","unstructured":"Francis GS. Development of arrhythmias in patients with congestive heart failure: Pathophysiology, prevalence, and prognosis. Am J Cardiol1986;87:3B-10B.","journal-title":"Am J Cardiol"},{"key":"5094287_CR2","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/0002-8703(71)90083-4","volume":"81","author":"HN Coleman","year":"1971","unstructured":"Coleman HN, Taylor RR, Pool PE, Wipple GH, Covell JN, Ross JR, Braunwald E. Congestive heart failure following chronic tachycardia. Am Heart J1971;81:75\u2013798.","journal-title":"Am Heart J"},{"key":"5094287_CR3","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/0002-9149(92)90705-4","volume":"69","author":"M Grogan","year":"1992","unstructured":"Grogan M, Smith HC, Gersh BL, Wood DL. Left ventricular dysfunction due to atrial fibrillation in patients initially belived to have idiopathic dilated cardiomyopathy. Am J Cardiol1992;69:157\u20131573.","journal-title":"Am J Cardiol"},{"issue":"SupplIV","key":"5094287_CR4","first-page":"28","volume":"75","author":"JT Bigger Jr.","year":"1987","unstructured":"Bigger JT Jr. Why patients with congestive heart failure die: Arrhythmias and sudden cardiac death. Circ1987;75 (Suppl IV):2\u201335.","journal-title":"Circ"},{"key":"5094287_CR5","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/BF00127406","volume":"1","author":"J Guido","year":"1997","unstructured":"Guido J, Bues Genis A, Dominguez de Rozas JM, Fiol M, Vinolas X, Bayes de Luna A. Sudden death in heart failure. Heart Failure Reviews1997;1:24\u2013260.","journal-title":"Heart Failure Reviews"},{"key":"5094287_CR6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","volume":"353","author":"CIBIS II InvestigatorsCommittes.","year":"1999","unstructured":"CIBIS II Investigators and Committes. The Cardiac Insu-ficiency Bisoprolol Study II (CIBIS II): A randomized trial. Lancet1999;353:\u201313.","journal-title":"Lancet"},{"key":"5094287_CR7","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","volume":"353","author":"MERIT-HF Study Group.","year":"1999","unstructured":"MERIT-HF Study Group. Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomized Inter-ventional Trial in Congestive Heart Failure (MERIT-HF). Lancet1999;353:200\u20132007.","journal-title":"Lancet"},{"key":"5094287_CR8","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM200105313442201","volume":"344","author":"M Packer","year":"2001","unstructured":"Packer M, Coats AJS, Fowler MB, Katus HA, Krum H, Mohacsi P, Rouleau JL, Tendera M, Castaigne A, Roecker EB, Schultz MK, DeMets DL, for the Carvedilol Prospec-tive Randomized Cumulative Survival Study Group. NEng J Me d 2001;344:165\u20131658.","journal-title":"NEng J Med"},{"key":"5094287_CR9","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199209033271001","volume":"327","author":"MA Pfeffer","year":"1992","unstructured":"Pfeffer MA, Braunwald E, Moyu LAS, et al. on behalf of the SAVE Investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction af-ter myocardial infarction. Results of the Survival and Ven-tricular Enlargement Trial. N Engl J Med1992;327:68\u2013 692.","journal-title":"N Engl J Med"},{"key":"5094287_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0002-9149(90)90125-K","volume":"65","author":"J Kjekshus","year":"1990","unstructured":"Kjekshus J. Arrhythmias and mortality in congestive heart failure. Amer J Cardiol1990;65:\u201342.","journal-title":"Amer J Cardiol"},{"key":"5094287_CR11","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1161\/01.CIR.80.6.1675","volume":"80","author":"M Luu","year":"1989","unstructured":"Luu M, Stevenson WG, Stevenson LW, Baron K, Warden J. Diverse mechanisms of unexpected cardiac arrests in ad-vanced heart failure. Circ1989;80:167\u20131680.","journal-title":"Circ"},{"key":"5094287_CR12","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0002-8703(85)90554-X","volume":"109","author":"CS Chakko","year":"1985","unstructured":"Chakko CS, Georghiade M. Ventricular arrhythmias in patients with congestive heart failure: Incidence, significance, and effectiveness of antiarrhythmic therapy. Am Heart J1985;109:49\u2013504.","journal-title":"Am Heart J"},{"key":"5094287_CR13","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJM198606123142404","volume":"314","author":"JN Cohn","year":"1996","unstructured":"Cohn JN, Archibald DG, Ziesche S, Francoisa JA, Harston WE, Tristani FE, et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. NEngl J Med1996;314:154\u20131552.","journal-title":"NEngl J Med"},{"key":"5094287_CR14","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1161\/01.CIR.91.10.2504","volume":"91","author":"JN Cohn","year":"1995","unstructured":"Cohn JN. Structural basis for heart failure: Ventricu-lar remodelling and its pharmacologic inhibition. Circ 1995;91:250\u20132507.","journal-title":"Circ"},{"key":"5094287_CR15","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJM197110142851602","volume":"285","author":"DL Eckberg","year":"1971","unstructured":"Eckberg DL, Drabinsky M, Braunwald E. Defective cardiac parasympathetic control of patients with heart disease. N Eng J Med1971;285:87\u2013883.","journal-title":"N Eng J Med"},{"key":"5094287_CR16","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/978-3-642-75326-8_3","volume-title":"Heart Failure and Arrhythmia s","author":"MJ Janse","year":"1990","unstructured":"Janse MJ, de Bakker JMT, Opthof T. Pathogenesis of ven-tricular arrhythmias in heart failure. In: Brachmann J, Dietz R, Kubler W, eds. Heart Failure and Arrhythmia s. Berlin: Springer Verlag, 1990:1\u201323."},{"key":"5094287_CR17","doi-asserted-by":"crossref","unstructured":"Brown MJ, Brown DC, Murphy MB. Hypokalemia from beta-2 receptor stimulation by circulating epinephrine. N Eng J Med309:141\u20131419.","DOI":"10.1056\/NEJM198312083092303"},{"key":"5094287_CR18","first-page":"541","volume":"5","author":"JR Damiano","year":"1985","unstructured":"Damiano JR, Tripp HF, Small KW, Asano T, Jones RH, Lowe JE. The functional consequences of pro-longed supraventricular tachycardia. J Am Coll Cardiol 1985;5:54\u2013547.","journal-title":"J Am Coll Cardiol"},{"key":"5094287_CR19","volume-title":"Molecular Basis of Heart Diseas e","author":"E Marban","year":"1998","unstructured":"Marban E. Molecular approaches to arrhythmogenesis. In: Chien K, ed. Molecular Basis of Heart Diseas e. New York: W.B. Saunders, 1998."},{"key":"5094287_CR20","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/00001573-200005000-00014","volume":"15","author":"FG Tomaselli","year":"2000","unstructured":"Tomaselli FG, Rosen J. Molecular aspects of arrhyth-mias associated with cardiomyopathies. Curr Opin Cardiol 2000;15:20\u2013208.","journal-title":"Curr Opin Cardiol"},{"key":"5094287_CR21","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S0008-6363(95)00073-9","volume":"30","author":"D Potreau","year":"1995","unstructured":"Potreau D, Gomez JP, Fares N. Depressed transient out-ward current in single hypertrophied cardiomyocytes iso-lated from the right ventricle of ferret heart. Cardiovasc Res1995;30:44\u2013448.","journal-title":"Cardiovasc Res"},{"key":"5094287_CR22","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1006\/jmcc.1996.0036","volume":"28","author":"D Thuringer","year":"1996","unstructured":"Thuringer D, Coulombe A, Derubaix E, Coraboeuf E, Mercadier JJ. Depressed transient outward current den-sity in ventricular myocytes from cardiomyopathic Syrian hamsters of different ages. J Mol Cell Cardiol1996;28:38\u2013 401.","journal-title":"J Mol Cell Cardiol"},{"key":"5094287_CR23","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1161\/01.RES.84.5.562","volume":"84","author":"B O'Rourke","year":"1999","unstructured":"O'Rourke B, Peng FL, K\u00e4\u00e4b S, Tunin R, Tomaselli GF, Marban E. Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart failure: Experimental studies. Circ Res1999;84:56\u2013570.","journal-title":"Circ Res"},{"key":"5094287_CR24","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1161\/01.RES.61.1.70","volume":"61","author":"JK Gwathmey","year":"1987","unstructured":"Gwathmey JK, Copellas L, MacKinnon R, Schoen RS, Feldman MD, Grossman W, Morgan JP. Abnormal intra-celllular calcium handling in myocardium from patients with end-stage heart failure. Circ Res1987;61:7\u201376.","journal-title":"Circ Res"},{"key":"5094287_CR25","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/cvr\/28.10.1547","volume":"28","author":"JT Vermeulen","year":"1994","unstructured":"Vermeulen JT, McGuire MA, Opthof T, Coronel R, deBakker JM, Klopping C, Janse MJ. Triggered activity and automaticity in ventricular trabeculae of failing human and rabbit hearts. Cardiovasc Res1994;28:154\u2013 1554.","journal-title":"Cardiovasc Res"},{"key":"5094287_CR26","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1161\/01.CIR.85.3.1046","volume":"85","author":"DJ Beuckelmann","year":"1993","unstructured":"Beuckelmann DJ, N\u00e4bauer M, Erdmann E. Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure. Circ Res1993;85:104\u2013 1055.","journal-title":"Circ Res"},{"key":"5094287_CR27","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/cvr\/28.7.933","volume":"28","author":"G Hart","year":"1994","unstructured":"Hart G. Cellular electrophysiology in cardiac hypertrophy and failure. Cardiovasc Res1994;28:93\u2013946.","journal-title":"Cardiovasc Res"},{"key":"5094287_CR28","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/00005344-199502000-00014","volume":"25","author":"H Uoadid","year":"1995","unstructured":"Uoadid H, Albat B, Nargeot J. Calcium currents in diseased human cardiac cells. J Cardiovasc Pharamcol 1995;25:28\u2013291.","journal-title":"J Cardiovasc Pharamcol"},{"key":"5094287_CR29","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0008-6363(95)00176-X","volume":"31","author":"H Reinecke","year":"1996","unstructured":"Reinecke H, Studer R, Vetter R, Holtz J, Drexler H. Cardiac Na +\/Ca2 + exchange activity in patients with end-stage heart failure. Cardiovasc Res1996;31:4\u201354.","journal-title":"Cardiovasc Res"},{"key":"5094287_CR30","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1161\/01.RES.75.3.473","volume":"75","author":"E Wettwer","year":"1994","unstructured":"Wettwer E, Amos GJ, Posival H, Ravens U. Transient outward current in human ventricular myocytes ofsubepicardial and subendocardial origin. Circ Res1994;75:47\u2013482.","journal-title":"Circ Res"},{"key":"5094287_CR31","first-page":"315","volume":"35","author":"SM Bryant","year":"1997","unstructured":"Bryant SM, Shipsey SJ, Hart G. Regional differences in electrical and mechanical properties of myocytes from guinea-pig hearts with mild left ventricular hypertrophy. J Am Coll Cardiol1997;35:31\u2013323.","journal-title":"J Am Coll Cardiol"},{"key":"5094287_CR32","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0735-1097(95)00167-X","volume":"26","author":"E Drouin","year":"1995","unstructured":"Drouin E, Charpentier F, Gauthier C, Laurent K, Le Marec H. Electrophysiologic characteristics of cells spanning the left ventricular wall of human heart: Evidence for presence of M cells. J Am Coll Cardiol1995;26:18\u2013192.","journal-title":"J Am Coll Cardiol"},{"key":"5094287_CR33","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1161\/01.CIR.96.5.1557","volume":"96","author":"RD Berger","year":"1997","unstructured":"Berger RD, Kasper EK, Baughman KL, Marba E, Calkins H, Tomaselli GF. Beat-to-beat QT interval variability: Novel evidence for repolarization lability in ischemic and nonischemic dilated cardiomyopathy. Circulation 1997;96:155\u20131565.","journal-title":"Circulation"},{"key":"5094287_CR34","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0140-6736(94)91164-9","volume":"343","author":"CS Barr","year":"1994","unstructured":"Barr CS, Naas A, Freeman M, Lang CC, Struthers AD. QT dispersion and sudden unexpected death in chronic heart failure. Lancet1994;343:32\u2013329.","journal-title":"Lancet"},{"key":"5094287_CR35","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0735-1097(83)80265-4","volume":"2","author":"JR Wilson","year":"1983","unstructured":"Wilson JR, Scwartz R, Sutton M-S, Ferrao N, Horowitz LN, Reichek N, Josephson ME. Prognosis in severe heart failure: Relationships to hemodynamic measurements and ventricular ectopic activity. J AmColl Cardiol1983;2:40\u2013 411.","journal-title":"J AmColl Cardiol"},{"key":"5094287_CR36","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/978-3-642-75326-8_19","volume-title":"Heart Failure and Arrhythmias","author":"B Singh","year":"1990","unstructured":"Singh B, Schoenbaum M, Antimisiaris, M, Takanaka C. Prognostic significance of asymptomatic ventricular arrhythmias in heart failure: Potential for mortality reduction by pharmacologic control. In: Brachmann J, Dietz R, Kubler W, eds. Heart Failure and Arrhythmias. Berlin: Springer Verlag, 1990:16\u2013173."},{"key":"5094287_CR37","doi-asserted-by":"crossref","first-page":"3B","DOI":"10.1016\/0002-9149(86)90991-4","volume":"57","author":"GS Francis","year":"1986","unstructured":"Francis GS. Development of arrhythmias in patients with congestive heart failure: Pathophysiology, prevalence and prognosis. Am J Cardiol1986;57:3B-10B.","journal-title":"Am J Cardiol"},{"key":"5094287_CR38","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM199507133330201","volume":"333","author":"SN Singh","year":"1995","unstructured":"Singh SN, Fletcher RD, Fisher SG, Singh BN, Lewis HD, Deedwania PC, Massie BM, Colling C, Lazzeri D. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J Med 1995;333:7\u201382.","journal-title":"N Engl J Med"},{"key":"5094287_CR39","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0735-1097(98)00338-6","volume":"32","author":"SN Singh","year":"1998","unstructured":"Singh SN, Fisher S, Carson PE, Fletcher RD and the Veter-ans Affairs CHF STAT Investigators. Prevalence and sig-nificance of nonsustained ventricular tachycardia in pa-tients with premature ventricular contractions and heart failure treated with vasodilator therapy. J AmColl Cardiol 1998;32:94\u2013947.","journal-title":"J AmColl Cardiol"},{"key":"5094287_CR40","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM199103213241201","volume":"324","author":"FD Echt","year":"1991","unstructured":"Echt FD, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, Arensberg D, Baker A, Friedman L, Greene L, Huther L, Richardson DW, and the CAST Investigators. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Ar-rhythmia Suppression Trial. N Engl J Med1991;324:78\u2013 788.","journal-title":"N Engl J Med"},{"key":"5094287_CR41","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1056\/NEJM199207233270403","volume":"327","author":"The Cardiac Arrhythmia Suppression Trial II Investigators.","year":"1992","unstructured":"The Cardiac Arrhythmia Suppression Trial II Investigators. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N Engl J Med 1992;327:22\u2013233.","journal-title":"N Engl J Med"},{"key":"5094287_CR42","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(94)91895-3","volume":"344","author":"HC Doval","year":"1994","unstructured":"Doval HC, Nul DR, Grancelli HD, Perrone SV, Bortman GR, Curiel R, for GESICA. Randomised trial of low-dose amiodarone in severe congestive heart failure. Lancet 1994;344:49\u2013498.","journal-title":"Lancet"},{"key":"5094287_CR43","first-page":"88","volume":"1","author":"BN Singh","year":"1996","unstructured":"Singh BN. Rise and fall of guided antiarrhythmic therapy for ventricular tachycardia and fibrillation. J Cardiovasc Pharmacol Therapeut1996;1:8\u201394.","journal-title":"J Cardiovasc Pharmacol Therapeut"},{"key":"5094287_CR44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/107424840100600101","volume":"6","author":"R Lazzara","year":"2001","unstructured":"Lazzara R. Will antiarrhythmic drug therapy guided by electrophysiology study survive in the new milleniumm. J Cardiovasc Pharmacol Therapeut2001;6:\u20134.","journal-title":"J Cardiovasc Pharmacol Therapeut"},{"key":"5094287_CR45","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJM198606123142404","volume":"314","author":"JN Cohn","year":"1986","unstructured":"Cohn JN, Archibald DG, Ziesche S. Effect of vasodilator therapy on mortality in chronic congestive heart failure. N Engl J Med1986;314:154\u20131553.","journal-title":"N Engl J Med"},{"key":"5094287_CR46","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1023\/A:1026518826171","volume":"4","author":"MJ Reiter","year":"2000","unstructured":"Reiter MJ. Antiarrhythmic impact of anti-ischemic and anti-failure and other cardiovascular strategies. Card Elec-trophysiol Rev2000;4:19\u2013205.","journal-title":"Card Elec-trophysiol Rev"},{"key":"5094287_CR47","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0002-9149(98)00468-8","volume":"82","author":"MJ Reiter","year":"1998","unstructured":"Reiter MJ, Reiffel JA. The importance of beta-blockade in the therapy of serious ventricular arrhythmias. Am J Car-diol 1998;82:9\u201398.","journal-title":"Am J Car-diol"},{"key":"5094287_CR48","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0002-8703(89)90670-4","volume":"117","author":"A Bayes de Luna","year":"1989","unstructured":"Bayes de Luna A, Counel P, Leclerq JF. Ambulatory cardiac death: Mechanism of production of fatal arrhythmia on the basis of data from 157 cases. A Heart J1989;117:15\u2013 158.","journal-title":"A Heart J"},{"key":"5094287_CR49","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0140-6736(96)09145-3","volume":"349","author":"DG Julian","year":"1997","unstructured":"Julian DG, Camm AJ, Frangin G, Janse MJ, Munoz A, Schwartz PJ, Simon P. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investiga-tors. Lancet1997;349:66\u2013674.","journal-title":"Lancet"},{"key":"5094287_CR50","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0140-6736(96)08171-8","volume":"349","author":"JA Cairns","year":"1997","unstructured":"Cairns JA, Connolly SJ, Roberts R, Gent M. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocar-dial Infarction Arrhythmia Trial Investigators. Lancet 1997;349:67\u2013682.","journal-title":"Lancet"},{"key":"5094287_CR51","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0002-9149(96)00452-3","volume":"78","author":"BN Singh","year":"1996","unstructured":"Singh BN. Antiarrhythmic actions of amiodarone: A profile of a paradoxical agent. Amer J Cardiol1996;78:4\u201353.","journal-title":"Amer J Cardiol"},{"key":"5094287_CR52","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/0735-1097(89)90030-2","volume":"14","author":"AWF Hamer","year":"1989","unstructured":"Hamer AWF, Arkles LB, Johns JA. Beneficial effects of low dose amiodarone in patients with heart failure: A placebo-controlled trial. Am J Cardiol1989;14:176\u20131773.","journal-title":"Am J Cardiol"},{"key":"5094287_CR53","unstructured":"Pinter, Dorian P. Interactions between implantable devices and antiarrhythmic drugs. Card Electrophysiol Rev 2000;22\u2013226."},{"key":"5094287_CR54","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJM199711273372202","volume":"337","author":"The Antiarrhythmics Versus Implantable Defibrillators","year":"1997","unstructured":"The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med1997;337:157\u20131583.","journal-title":"N Engl J Med"},{"key":"5094287_CR55","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1161\/01.CIR.101.11.1297","volume":"101","author":"SJ Connolly","year":"2000","unstructured":"Connolly SJ, Gent M, Roberts RS, et al. The CIDs Investiga-tors. Canadian Implantable Defibrillator Study (CIDS). A randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation2000;101:129\u20131304.","journal-title":"Circulation"},{"key":"5094287_CR56","first-page":"748","volume":"102","author":"K-H Kuck","year":"2000","unstructured":"Kuck K-H, Cappato R, Siebels, et al. Randomized com-parison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest. The Cardiac Arrest Study from Hamburg2000;102:74\u2013 754.","journal-title":"The Cardiac Arrest Study from Hamburg"},{"key":"5094287_CR57","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0735-1097(99)00327-7","volume":"34","author":"M Domansky","year":"1999","unstructured":"Domansky M, Sakseena S, Epstein AE, et al. Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular function who have survived malignant ventricular arrhythmias. AVID Investigators. Antiarrhythmics versus implantable defibrillators. J Am Coll Cardiol1999;34:109\u20131098.","journal-title":"J Am Coll Cardiol"},{"key":"5094287_CR58","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJM199612263352601","volume":"335","author":"AJ Moss","year":"1996","unstructured":"Moss AJ, Hall WJ, Cannom DS, et al. For the Multicenter Automatic Defibrillator Implantation Investigators. Im-proved survival with an implantable defibrillator in pa-tients with coronary artery disease at high risk for ven-tricular arrhythmias. N Eng J Med1996;335:193\u20131939.","journal-title":"N Eng J Med"},{"key":"5094287_CR59","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1161\/01.CIR.82.2.350","volume":"82","author":"DJ Wilber","year":"1990","unstructured":"Wilber DJ, Olshansky B, Moran JF, et al. Electrophysiologic testing and nonsustained ventricular tachycardia: Use and limitation in patients with coronary artery dis-ease and impaired ventricular function. Circ1990;82:35\u2013 358","journal-title":"Circ"},{"key":"5094287_CR60","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1056\/NEJM199912163412503","volume":"341","author":"AE Buxton","year":"1999","unstructured":"Buxton AE, Lee KL, Fisher JD, et al. For the Multicenter Unsustained Ventricular Tachycardia Trial (MUSTT). N Eng J Med1999;341:188\u20131891.","journal-title":"N Eng J Med"},{"key":"5094287_CR61","first-page":"20","volume":"22","author":"AJ Moss","year":"1999","unstructured":"Moss AJ, Cannom DS, Daubert J, Hall W, Higgins S, Klein H, Wilber D, Zareba W, Brown M. Multicenter Automatic Defibrillator Trial II (MADIT II): Design and clinical protocol. Ann Noninvasive Electrocardiol1999;22:2\u2013 27.","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"5094287_CR62","doi-asserted-by":"crossref","first-page":"63R","DOI":"10.1016\/S0002-9149(99)00704-3","volume":"84","author":"A Zivin","year":"1999","unstructured":"Zivin A, Bardy GH. Implantable defibrillators and antiar-rhythmic drugs in patients at risk lethal arrhythmias. Am J Cardiol1999;84:63R-68R.","journal-title":"Am J Cardiol"},{"issue":"6","key":"5094287_CR63","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1161\/01.CIR.93.6.1262","volume":"93","author":"EN Prystowsky","year":"1996","unstructured":"Prystowsky EN, Benson DW Jr, Fuster VH, Robert G, Kay GN, Myerburg RJ, Naccarelli GV, Wyse DG. Management of Patients With Atrial Fibrillation: A Statement for Healthcare Professionals From the Subcommittee on Electrocardiography, American Heart Association. Circulation 1996;93(6):126\u20131277.","journal-title":"Circulation"},{"key":"5094287_CR64","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1001\/jama.1994.03510350050036","volume":"271","author":"EJ Benjamin","year":"1994","unstructured":"Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort study: The Framingham Heart Study. JAMA1994;271:84\u2013844.","journal-title":"JAMA"},{"key":"5094287_CR65","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/0002-9149(94)90363-8","volume":"74","author":"CD Furberg","year":"1994","unstructured":"Furberg CD, Psaty BM, Manolio TA, Gardin JM, Smith VE, Rautaharju RM. Prevalence of atrial fibrillation in elderly subjects: The Cardiovascular Health Study. Am J Cardiol 1994;74:23\u2013241.","journal-title":"Am J Cardiol"},{"key":"5094287_CR66","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1445-5994.1989.tb00271.x","volume":"19","author":"RR Lake","year":"1989","unstructured":"Lake RR, Cullen KJ, de Klerk NH, McCall MG, Rosman DL. Atrial fibrillation in an elderly population. Aust N Z J Med1989;19:32\u2013326.","journal-title":"Aust N Z J Med"},{"key":"5094287_CR67","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","volume":"22","author":"PA Wolf","year":"1991","unstructured":"Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke1991;22:98\u2013988.","journal-title":"Stroke"},{"key":"5094287_CR68","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S0025-6196(12)62535-X","volume":"65","author":"SJ Philips","year":"1990","unstructured":"Philips SJ, Whisnant J, O'Fallon WM, Frye RL. Preva-lence of cardiovascular disease and diabetes in residents of Rochester, Minnesota. Mayo Clin Proc1990;65:34\u2013 359.","journal-title":"Mayo Clin Proc"},{"key":"5094287_CR69","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/archinte.1995.00430050045005","volume":"155","author":"WM Feinberg","year":"1995","unstructured":"Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation. Arch Intern Med 1995;155:46\u2013473.","journal-title":"Arch Intern Med"},{"key":"5094287_CR70","doi-asserted-by":"crossref","unstructured":"Deedwania PC, Singh BN, Ellenbogan K, Fisher S, Fletcher R, Singh SN for the Department of Veterans Affairs CHF-STAT Investigators. Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation. Observations from the Veterans Affairs Congestive Heart Failure Survival Trial of Antiarrhythmic Therapy (CHF-STAT). Circ1998;257\u2013 2579.","DOI":"10.1161\/01.CIR.98.23.2574"},{"key":"5094287_CR71","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0002-8703(59)90274-1","volume":"58","author":"GK Moe","year":"1959","unstructured":"Moe GK, Abildskov JA. Atrial Fibrillation as a self-sustaining arrythmia independent of focal discharge. Amer Heart J1959;58:5\u201370.","journal-title":"Amer Heart J"},{"key":"5094287_CR72","first-page":"183","volume":"140","author":"GK Moe","year":"1962","unstructured":"Moe GK. On the multiple wavelet hypothesis of atrial fibrillation. Arch Int Pharmacodyn Ther1962;140:18\u2013 188.","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"5094287_CR73","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0002-8703(64)90371-0","volume":"67","author":"GK Moe","year":"1964","unstructured":"Moe GK, Rheinboldt WC, Abildskov JA. A computer model of atrial fibrillation. Amer Heart J1964;67:20\u2013220.","journal-title":"Amer Heart J"},{"key":"5094287_CR74","first-page":"265","volume-title":"Cardiac Electrophysiology and Arrhythmia s","author":"MA Allessie","year":"1985","unstructured":"Allessie MA, Lammers WJEP, Bonke FIM, Hollen J. Experimental evaluation of Moe's multiple wavelet hypothesis of atrial fibrillation. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology and Arrhythmia s. Orlando, FL: Grune & Stratton, 1985:26\u2013276."},{"key":"5094287_CR75","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1161\/01.CIR.82.1.274","volume":"82","author":"Z Wang","year":"1990","unstructured":"Wang Z, Pelletier LC, Talajic M, Nattel S. Effects of fle-cainide and quinidine. On human atrial potentils: Role of rate dependence and comparison with guinea pig, rabbit and dog tissues. Circulation1990;82:27\u2013283.","journal-title":"Circulation"},{"key":"5094287_CR76","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1161\/01.CIR.92.7.1954","volume":"92","author":"MCEF Wijffels","year":"1995","unstructured":"Wijffels MCEF, Kirchhof CJHJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation: A study in awake chronically instrumented goats. Circulation 1995;92:195\u20131968.","journal-title":"Circulation"},{"key":"5094287_CR77","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/00005344-199502000-00014","volume":"25","author":"H Ouadid","year":"1995","unstructured":"Ouadid H, Albat B, Nargeot J. Calcium currents in diseased human cardiac cells. J Cardiovasc Pharmacol 1995;25:28\u2013291.","journal-title":"J Cardiovasc Pharmacol"},{"key":"5094287_CR78","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1093\/cvr\/28.4.548","volume":"28","author":"B Le Grand","year":"1994","unstructured":"Le Grand B, Hatem S, Deroubaix E, et al. Depressed tran-sient outward and calcium currents in dilated human atria. Cardiovasc Res1994;28:54\u2013556.","journal-title":"Cardiovasc Res"},{"key":"5094287_CR79","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1161\/01.CIR.90.5.2213","volume":"90","author":"SI Koumi","year":"1994","unstructured":"Koumi SI, Arentzen CE, Backer CL, et al. Alterations in muscarinic K channel response to acetylcholine and to G protein-mediated activation in atrial myocytes isolated from failing human hearts. Circulation1994;90:221\u2013 2224.","journal-title":"Circulation"},{"key":"5094287_CR80","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1161\/01.RES.80.6.772","volume":"80","author":"DR Van Wagoner","year":"1997","unstructured":"Van Wagoner DR, Pond AL, McCarthy PM, et al. Outward K+ current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation. Circ Res 1997;80:77\u2013781.","journal-title":"Circ Res"},{"key":"5094287_CR81","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/0002-9149(92)90705-4","volume":"69","author":"M Grogan","year":"1992","unstructured":"Grogan M, Smith HC, Gersh BL, Wood DL. Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. Am J Cardiol1992;69:157\u20131573.","journal-title":"Am J Cardiol"},{"key":"5094287_CR82","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/0735-1097(89)90602-5","volume":"13","author":"W Manning","year":"1989","unstructured":"Manning W, Leeman DE, Gotch PJ, Come PC. Pulsed Doppler evaluation of atrial mechanical function after electrical cardioversion of atrial fibrillation. J Am Coll Cardiol 1989;13:61\u2013623.","journal-title":"J Am Coll Cardiol"},{"key":"5094287_CR83","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/S0002-9149(97)00082-9","volume":"79","author":"AFFIRM Investigators.","year":"1997","unstructured":"AFFIRM Investigators. Atrial fibrillation following inves-tigation of rhythm management the AFFIRM study design. Am J Cardiol1997;79:119\u20131202.","journal-title":"Am J Cardiol"},{"key":"5094287_CR84","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt B, Zannard F, Remme WJ, et al. The effect of spirono-lactone on morbidity and mortality in patients with severe heart failure. New Eng J Med1999;341:70\u2013717.","journal-title":"New Eng J Med"},{"key":"5094287_CR85","doi-asserted-by":"crossref","first-page":"139R","DOI":"10.1016\/S0002-9149(99)00714-6","volume":"84","author":"P Jais","year":"1999","unstructured":"Jais P, Shah DC, Haissaguerre M, et al. Efficacy and safety of septal and left atrial linear ablation for atrial fibrillation. Am J Cardiol1999;84:139R-146R.","journal-title":"Am J Cardiol"},{"key":"5094287_CR86","doi-asserted-by":"crossref","first-page":"115R","DOI":"10.1016\/S0002-9149(99)00762-6","volume":"84","author":"GK Feld","year":"1999","unstructured":"Feld GK. Evolution of diagnostic and interventional cardiac electrophysiology: A brief historical review. Am J Cardiol1999;84:115R-124R.","journal-title":"Am J Cardiol"},{"key":"5094287_CR87","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/0003-4975(93)90338-I","volume":"56","author":"JL Cox","year":"1993","unstructured":"Cox JL, Boineau JP, Schuessler RB, et al. Five year ex-perience with the maze procedure atrial fibrillation. Ann Thorac Surg1993;56:81\u2013824.","journal-title":"Ann Thorac Surg"},{"issue":"6A","key":"5094287_CR88","doi-asserted-by":"crossref","first-page":"3D","DOI":"10.1016\/S0002-9149(98)00147-7","volume":"81","author":"BN Singh","year":"1998","unstructured":"Singh BN. Antiarrhythmic drugs: A re-orientation in light of recent developments in the control of disorders of rhythm. Amer J Cardiol1998;81(6A):3D-13D.","journal-title":"Amer J Cardiol"},{"key":"5094287_CR89","first-page":"11R","volume":"84","author":"BN Singh","year":"1999","unstructured":"Singh BN. Overview of trends in the control of cardiac ar-rhythmias: Past and future. Am J Cardiol1999;84:11R- 19R.","journal-title":"Am J Cardiol"},{"key":"5094287_CR90","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1540-8167.1995.tb00365.x","volume":"6","author":"BN Singh","year":"1995","unstructured":"Singh BN. Expanding indications for the use of class III antiarrhythmic agents in patients at high risk for sudden death. J Cardiovasc Electrophysiol1995;6:88\u2013909.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"5094287_CR91","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/107424849900400108","volume":"4","author":"BN Singh","year":"1999","unstructured":"Singh BN. Sotalol: Current status and expanding indi-cations. J Cardiovasc Pharmacol Therap1999;4:4\u201365; Singh BN. Antiarrhythmic actions of amiodarone: A profile of a paradoxical agent. Amer J Cardiol1996;78:4\u201353.","journal-title":"J Cardiovasc Pharmacol Therap"},{"key":"5094287_CR92","doi-asserted-by":"crossref","first-page":"161R","DOI":"10.1016\/S0002-9149(99)00718-3","volume":"84","author":"BN Singh","year":"1999","unstructured":"Singh BN, Mody FV, Lopez B, Sarma JSM. Antiarrhythmic agents for atrial fibrillation: Focus on prolonging atrial re-polarization. Amer J Cardiol1999;84:161R-173R.","journal-title":"Amer J Cardiol"},{"key":"5094287_CR93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/107424849700200101","volume":"2","author":"BN Singh","year":"1997","unstructured":"Singh BN. Class III antiarrhythmic drugs: Simple versus complex molecules for controlling cardiac arrhythmias. J Cardiovasc Pharamcol Therapeut1997;2:\u20136.","journal-title":"J Cardiovasc Pharamcol Therapeut"},{"key":"5094287_CR94","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1056\/NEJM199909163411201","volume":"341","author":"C Torp-Pedersen","year":"1999","unstructured":"Torp-Pedersen C, Moeller M, Bloch-Thomsen P, et al. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. N Eng J Med1999;341:85\u2013865.","journal-title":"N Eng J Med"},{"key":"5094287_CR95","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1161\/01.CIR.84.1.40","volume":"84","author":"HR Middlekauff","year":"1991","unstructured":"Middlekauff HR, Stevenson WG, Stevenson LW. Prognostic significance of atrial fibrillation in advanced heart failure: A study of 390 patients. Circ1991;84:4\u201348.","journal-title":"Circ"},{"key":"5094287_CR96","first-page":"383","volume":"9681","author":"SN Singh","year":"1997","unstructured":"Singh SN, Berk MR, Yellen LG, Zoble RG, Abrahamson D, Billling C, Satler C, Friedrich T, and te Dofetilide Atrial Fibrillation Investigators. Efficacy and safety of oral dofetilide in maintaining normal sinus rhythm in patients with atrial fibrillation\/flutter: A multicenter study. Circ 1997;96(8)1:383.","journal-title":"Circ"},{"key":"5094287_CR97","unstructured":"AF-AF-CHF. Multicenter international study evaluating the value of a therapeutic strategy to restore and maintain sinus rhythm in patients with AF and CHF versus a strategy of rate control. Study initiated (Principal Investigator: D. Roy). 2001."}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1020001912248.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1020001912248\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1020001912248.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T10:58:54Z","timestamp":1747997934000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1020001912248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7]]},"references-count":97,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,7]]}},"alternative-id":["5094287"],"URL":"https:\/\/doi.org\/10.1023\/a:1020001912248","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,7]]}}}